Tibra Equities Europe’s Astrana Health ASTH Stock Holding History

Tibra Equities Europe’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-58,180	Closed	-$928K	–	215
2018 Q1	$928K	Buy	+58,180	New	+$1.21M	0.16%	83

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Tibra Equities Europe's ASTH Position: Q2 2018 in Review

Tibra Equities Europe sold out of Astrana Health (ASTH) in Q2 2018, closing a stake of 58,180 shares — an estimated $928K sold.

Tibra Equities Europe first reported a position in ASTH in Q1 2018 and held it in 1 quarter. The position peaked at $928K in Q1 2018. 32 funds tracked by Wall St. Rank hold ASTH as of Q2 2018.

Tibra Equities Europe reported no remaining Astrana Health position as of Q2 2018 after selling out during the quarter.
Tibra Equities Europe sold 58,180 Astrana Health shares in Q2 2018, an estimated $928K.
Tibra Equities Europe first reported a position in Astrana Health in Q1 2018 and held it in 1 quarter.
Tibra Equities Europe's Astrana Health position peaked at $928K in Q1 2018.
32 funds tracked by Wall St. Rank held Astrana Health as of Q2 2018.

Based on Tibra Equities Europe's 13F filing for Q2 2018, filed 10 Aug 2018.